ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,037.59
1.06%
Dow Jones
43,325.80
0.07%
US Dollar vs MXN
20.2288
0.05%
Brent Oil
72.89
0.00%
Bitcoin
95,667.87
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE

  6. Ingevity Corporation (NGVT) Cotización

Ingevity Corporation

Ingevity Corporation (NGVT)

NYSE
41.75
0.29
(0.70%)
Al cierre: 26 Diciembre 3:00PM
Delayed by 15 minutes
41.75
0.00
( 0.00% )
Fuera de horario: 6:26PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
41.75
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
95,633
40.91 Rango del Día 41.89
30.8995 Rango de 52 semanas 56.295
Capitalización de Mercado [m]
1.518B
Precio Anterior
41.46
Precio de Apertura
40.93
Hora
23712
@
41.75
Última hora de negociación
18:00:00
Volumen financiero
US$ 3,977,410
Precio Promedio Ponderado
41.5904
Volumen promedio (3 m)
332,711
Acciones en circulación
36,349,108
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-280.89
Beneficio por acción (BPA)
-0.15
turnover
1.69B
Beneficio neto
-5.4M

Acerca de Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of special... Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America. Mostrar más

Sector
Chemicals & Allied Products
Industria
Chemicals & Allied Products
Sitio web
www.ingevity.com
Sede
Wilmington, Delaware, USA
Fundado
-
Ingevity Corporation is listed in the Chemicals & Allied Products sector of the New York Stock Exchange with ticker NGVT. The last closing price for Ingevity was US$41.46. Over the last year, Ingevity shares have traded in a share price range of US$ 30.8995 to US$ 56.295.

Ingevity currently has 36,349,108 shares in issue. The market capitalisation of Ingevity is US$1.51 billion. Ingevity has a price to earnings ratio (PE ratio) of -280.89.

NGVT Últimas noticias

Más noticias

Form 8-K - Current report

16 Diciembre 2024
Edgar (US Regulatory)

Ingevity elects Kevin Willis to its board of directors

Accomplished chemical industry CFO brings substantial finance and capital management expertise and experience driving corporate transformation Ingevity Corporation (NYSE:NGVT) today announced the...

16 Diciembre 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

30 Octubre 2024
Edgar (US Regulatory)

Form 8-K - Current report

29 Octubre 2024
Edgar (US Regulatory)

Ingevity reports third quarter 2024 financial results

HIGHLIGHTS: Net sales of $376.9 million, down 16% compared to prior year, primarily due to repositioning actions in Performance Chemicals Net loss of $107.2 million and diluted loss per share of...

29 Octubre 2024
Business Wire

Form 8-K - Current report

25 Octubre 2024
Edgar (US Regulatory)

Ingevity updates third-quarter 2024 earnings release and webcast dates

Ingevity Corporation (NYSE:NGVT) announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024. The company will host a live...

16 Octubre 2024
Business Wire

Form 8-K - Current report

03 Octubre 2024
Edgar (US Regulatory)

Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO

Ingevity Corporation (NYSE: NGVT) today announced that John Fortson has departed as president and chief executive officer and from the board of directors of the company, effective as of October...

03 Octubre 2024
Business Wire

Ingevity to highlight its newest Capa® polycaprolactone polyols at the 2024 Polyurethanes Technical Conference

Ingevity Corporation (NYSE:NGVT) will launch Capa® HS, the next generation of polycaprolactone polyols for enhanced hydrolytic resistance in polyurethanes, at the Center for the Polyurethanes...

30 Septiembre 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.56-1.3235641692342.3142.3640.402536671440.87785344CS
4-5.905-12.391144685847.6555040.402524993544.44589695CS
129.8931.042059008231.8651.6730.899533271140.96241994CS
26-1.57-3.624192059143.3251.6730.899529433040.1989863CS
52-6.39-13.273784794348.1456.29530.899526388843.10823565CS
156-30.3-42.05412907772.0590.830.899525823555.17766124CS
260-46.6-52.744765138788.3590.824.9228125758.09935338CS

NGVT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ingevity?
El precio actual de las acciones de Ingevity es US$ 41.75
¿Cuántas acciones de Ingevity están en circulación?
Ingevity tiene 36,349,108 acciones en circulación
¿Cuál es la capitalización de mercado de Ingevity?
La capitalización de mercado de Ingevity es USD 1.51B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ingevity?
Ingevity ha negociado en un rango de US$ 30.8995 a US$ 56.295 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ingevity?
El ratio precio/beneficio de Ingevity es -280.89
¿Cuál es el ratio de efectivo a ventas de Ingevity?
El ratio de efectivo a ventas de Ingevity es 0.9
¿Cuál es la moneda de reporte de Ingevity?
Ingevity presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Ingevity?
El último ingresos anual de Ingevity es USD 1.69B
¿Cuál es el último beneficio anual de Ingevity?
El último beneficio anual de Ingevity es USD -5.4M
¿Cuál es la dirección registrada de Ingevity?
La dirección registrada de Ingevity es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Ingevity?
La dirección del sitio web de Ingevity es www.ingevity.com
¿En qué sector industrial opera Ingevity?
Ingevity opera en el sector CHEMICALS & ALLIED PRODUCTS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
SESSES AI Corporation
US$ 1.79
(26.06%)
8.05M
ENFYEnlightify Inc
US$ 1.37
(19.13%)
540
ALURAllurion Technologies Inc
US$ 0.50
(15.47%)
18.57k
PSQHPSQ Holdings Inc
US$ 4.92
(6.03%)
285.7k
APAmpco Pittsburgh Corp
US$ 2.15
(5.91%)
618
NTZNatuzzi S P A
US$ 4.01
(-12.45%)
14.31k
BSTZBlackRock Science and Technology Term Trust
US$ 20.40
(-6.21%)
1.42k
MSCStudio City International Holdings Limited
US$ 6.10
(-5.72%)
11.65k
MPLNChurchill Capital Corp III
US$ 11.95
(-4.86%)
1.44k
STGSunlands Technology Group
US$ 6.00
(-4.61%)
34.97k
SESSES AI Corporation
US$ 1.76
(23.94%)
8.06M
SRESempra
US$ 87.61
(0.00%)
5.55M
ORealty Income Corporation
US$ 53.065
(-0.01%)
3.19M
TGNATEGNA Inc
US$ 18.58
(0.16%)
2.82M
PFEPfizer Inc
US$ 26.55
(-0.04%)
2.5M

Discusión

Ver feed completo
EmpressMonk25 EmpressMonk25 2 minutos hace
Just to put my speculation to work if you're going to...

$5000 today buys 6,250,000 shares

If company fully dilutes 50B shares and company does 1 for 500 RS, the new outstanding would be 100M

New holdings after RS 12,500 shares

$4 stock pri
HMBL
Hopeforthefuture3 Hopeforthefuture3 2 minutos hace
Good one - lol! Merck I believe spent many $ on buying into some company with a phase 1 trial, too bad did not send a few millions to nwbo.
I do hope Merck buys nwbo as can explore the potential of dcvax a.d direct in a timely fashion
No year+ to write a SAP and another year to make a
NWBO
getmoreshares getmoreshares 2 minutos hace
most of us are angles! couple devils show up now and then.
CGAC
tothe tothe 3 minutos hace
Is Melvin using the AI to reconstruct the website? I am under the impression that he is now using the AI on the Accounts Receivable platform and has time to extend (play?) its capabilities.
https://veemost.com/2023-end-of-quarter-shareholder-update/
GDVM
manibiotech manibiotech 3 minutos hace
style="font-kerning: none"
NWBO
JJ8 JJ8 4 minutos hace
Here, Where are you now?

I never traded since then.

My price at entry was $5.985

Now price at $24, my investment represents 301% growth.

Hope you re-bought the entire float again, lol.
SOUN
Penny Stocks 2.0 Penny Stocks 2.0 5 minutos hace
99% of the OTC splits are used to dilute, and usually happen because there's billions of outstanding shares. $HLLK only has 523m Total Outstanding Shares, canceled millions of Convertibles, returned 98m shares from BAH and canceled $243,000 in Legacy shares. The icing on the cake is the Anti-Dilutio
HLLK
gp22 gp22 5 minutos hace
$KWE: Nano-floater starting to rip in AHs...Some of you folks really know how to pick stocks!. Congrats.
KWE
Investor082 Investor082 5 minutos hace
The message is clear. BP is not giving any money to NWBO. There is no negotiation going behind the scenes. The combo trial will not get off the ground in 2025. No hiring in the UK and commercialization there is at least 18 months away.
NWBO
Diamondhands45 Diamondhands45 6 minutos hace
.002 tomorrow IMO
RDAR
RIGATONI RIGATONI 7 minutos hace
LODE .705 with 182k buy ~Rig
rodeoup rodeoup 7 minutos hace
In all my years of trading, this is the first time I’ve ever only held one company on the OTC. Call it stupid, uninformed or extremely smart. I’m betting on extremely smart, because I know what I’ve seen, I know what I’ve been told, I know what I’ve heard, and I know what I’ve researched. For me 20
NBRI
Diamondhands45 Diamondhands45 7 minutos hace
Holding 30 since .0009 there 
i_like_bb_stock i_like_bb_stock 7 minutos hace
CNEY moving now usually a banger the following day 
CNEY
i_like_bb_stock i_like_bb_stock 9 minutos hace
CNEY moving now usually a banger the following day 
CNEY
m$teamworkotc m$teamworkotc 11 minutos hace
0015 tommorrow?
HMBL
Elroy Jetson Elroy Jetson 11 minutos hace
That's why Republicans feel such an urgent need to surrender to Vladimir Putin as soon as possible.

It's hard to believe Mike Pompeo has been frozen out of this new administration, after he had formulated such an astoundingly straight-forward surrender plan.

I suppose T
georgie18 georgie18 13 minutos hace
Yes I see...thanks...careful though...🥳... https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=333-273934
QSI
imbellish imbellish 13 minutos hace
https://abcnews.go.com/US/wireStory/nebraska-man-lost-home-588-debt-back-117125341
FNMA
thehawk72 thehawk72 13 minutos hace
2024....can't do this another year. When was the last time we heard from Ken...April, March?
WDLF
EpicNavigator33 EpicNavigator33 14 minutos hace
Some people pay good money to get bent over a barrel lol
HMBL
rx7171 rx7171 14 minutos hace
Can we get the peer review article out prior to JPM?
Priming the pump for Missling’s long presentation in the biggest hall in the house.
JPM
Monroe1 Monroe1 14 minutos hace
hahahahah sure thing buddy. scratch the fake news barrel bottom. losers just can't get over it. some though have seen the light.
Senator Joe Manchin, once a lifelong Democrat, departs from the Senate with a scathing critique of the Democratic Party and a call for a centrist movement.
A
skitahoe skitahoe 15 minutos hace
I believe that if you believe in what management is doing you understand that they have a plan for growing the company, and it's stock price, and it requires the dilution they're doing. If you don't believe that, why be invested in the stock.

To me, far to many people are only concer
CRTG
Joelzee Joelzee 15 minutos hace
Right. Makes me wish I bought more. 
EOSE

Su Consulta Reciente

NYSE
NGVT
Ingevity
DOWI
DJUSNC
DJ US Consumer Goods
UNSW
BURPETH
Burp (CoinBurp)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados